Frequently Asked Questions

If you are currently experiencing neurological injury from a psychiatric medication, whether you are still taking it, tapering, or have already discontinued, there are unfortunately no guaranteed treatments. The medical system has not yet developed reliable interventions for medication-induced neurological damage. What does appear to help:

Time. The nervous system has a capacity for repair, but it is slow. Many people do improve over months and years, even from severe injury. Recovery is not linear, expect waves and windows of improvement interspersed with setbacks.

Dietary intervention. A strict ketogenic or carnivore diet is the single most commonly reported intervention that helps mitigate the severity of symptoms. It does not work for everyone, but for those it helps, the effect can be substantial.

Avoid further pharmacological insult. The injured nervous system is sensitized. Additional medications, even those prescribed to treat your symptoms, can cause disproportionate harm. Be extremely cautious with any new drugs, supplements, or substances. This includes alcohol, cannabis, and caffeine, which can destabilize a nervous system in recovery.

Reduce stress and protect sleep. The nervous system heals during rest. Chronic stress, sleep deprivation, and overstimulation slow recovery. This is not wellness advice, it is neurological reality. Many patients find that their baseline improves significantly when they are able to reduce the demands on their nervous system.

For detailed information on specific medication injuries, see our pages on SSRIs, SNRIs, benzodiazepines, antipsychotics, Accutane, fluoroquinolones, and finasteride. For support communities of people navigating recovery, see our resources page.

As far as we currently know, hyperbolic tapering is the safest method available for reducing and discontinuing psychiatric medications and other drugs that alter brain chemistry. It does not work for everyone, and some people sustain lasting neurological injury despite a careful taper, but it is the best option we currently have. The relationship between dose and receptor occupancy is hyperbolic, meaning that at lower doses, even small absolute reductions cause disproportionately large neurological effects. Hyperbolic tapering, where each successive reduction is progressively smaller in absolute terms, is the most pharmacologically rational approach available based on receptor occupancy principles. This typically requires liquid formulations or compounding pharmacies for the tiny reductions needed at lower doses.

Do not stop any psychiatric medication abruptly. Abrupt cessation can cause severe withdrawal, seizures (with benzodiazepines), supersensitivity psychosis (with antipsychotics), and neurological injury that may be extremely long-lasting. Even if you are experiencing adverse effects, work with a clinician to develop a gradual tapering plan.

An important reality: Some people sustain neurological injury while still taking these medications, before any taper is even started. There is no clear medical treatment for this kind of injury. The only things that appear to help are time and, in some cases, a ketogenic diet to mitigate symptom severity.

When tapering may not be appropriate: For some patients, particularly older adults (65+) stable on a medication for many years, the risks of tapering may outweigh the risks of staying on it. An 80-year-old functioning well on a benzodiazepine they've taken for 20 years has a nervous system in a stable equilibrium, and disrupting it risks falls, cognitive destabilization, and protracted withdrawal their aging nervous system may not complete. This does not apply to people actively experiencing adverse effects, on escalating doses, on recently started medications, or younger patients with better neuroplasticity for recovery. Anyone who wants to discontinue after genuine informed consent has every right to do so.

The one exception for rapid discontinuation: If acute akathisia or other acute adverse symptoms develop after starting a new medication or increasing a dose, the offending change should be reversed promptly. Akathisia is a life-threatening emergency and dependence has not yet formed at the new dose. In severe cases where akathisia is intolerable, there is emerging clinical evidence that moderate doses of opioid agonists such as oxycodone or hydromorphone can attenuate suicidal agitation while the offending agent is cleared.

A physician who insists every elderly patient must taper is as dangerous as one who insists these medications are harmless. Free tapering guides from communities like Surviving Antidepressants and Benzodiazepine Information Coalition are based on years of collective patient experience and may be safer than a conventional linear taper. For specialist clinics, see our tapering services section.

The most important step is to taper slowly using the hyperbolic method. Beyond that, the following may help:

A ketogenic diet or carnivore diet may help mitigate withdrawal severity for some patients.

Avoid further pharmacological insult. The withdrawing nervous system is sensitized. Additional medications, even those prescribed to treat your symptoms, can cause disproportionate harm. Be extremely cautious with any new drugs, supplements, or substances.

Protect sleep and reduce stress. The nervous system heals during rest. Many patients find that their baseline improves significantly when they are able to reduce the demands on their nervous system.

For a full list of tapering clinics and services that understand hyperbolic tapering, see our tapering services section.

A growing number of patients report significant improvement in neurological symptoms with strict ketogenic or carnivore diet adherence. This is not a fringe claim, there is established research on the neuroprotective effects of ketosis, including reduced neuroinflammation, stabilized neuronal excitability, and enhanced mitochondrial function. For a nervous system that has been damaged by medication, these mechanisms may support healing.

The ketogenic diet is a high-fat, very low-carbohydrate diet that shifts the body's primary fuel source from glucose to ketones. In the context of neurological injury, the relevant effects include reduced glutamate excitotoxicity, enhanced GABA signaling, and decreased neuroinflammation, all of which are directly relevant to the neurological damage caused by psychiatric medications.

The carnivore diet, eating exclusively animal products, is an elimination diet that some patients find more effective than standard keto, potentially because it removes all plant-based compounds that could trigger immune or inflammatory responses in a sensitized nervous system.

Important: This requires strict adherence to see results. Partial compliance typically does not produce meaningful benefit. Most patients who report improvement needed several weeks of strict adherence before noticing changes. It is not a cure, but for those it helps, it can meaningfully reduce the severity of symptoms.

This is one of the hardest parts of navigating medication-induced injury. Most physicians, including most psychiatrists, have received little to no training on protracted withdrawal, medication-induced neurological injury, or hyperbolic tapering. Many will dismiss your symptoms, attribute them to your underlying condition, or prescribe additional medications that make things worse.

Specialist tapering clinics are the most reliable option. Our tapering services section lists clinics that explicitly practice hyperbolic tapering based on receptor occupancy principles, including TaperClinic (virtual, nationwide US) and Outro Health (co-founded by Dr. Mark Horowitz, the researcher who established the scientific basis for hyperbolic tapering).

If you cannot access a specialist: Free tapering guides developed by patient communities may be safer than working with a doctor who is unfamiliar with hyperbolic tapering and insists on conventional linear dose reductions. Resources like Surviving Antidepressants, Benzodiazepine Information Coalition, and BenzoBuddies provide detailed, peer-reviewed tapering protocols developed over years of collective experience. A doctor who is willing to learn about hyperbolic tapering and work collaboratively with you is valuable, but a doctor who dismisses the concept and forces a rapid taper can cause serious harm.

Red flags in a physician: Insists withdrawal lasts only 2–4 weeks. Dismisses your symptoms as "anxiety" or "relapse." Recommends stopping a medication over days or weeks rather than months. Is unfamiliar with hyperbolic tapering or receptor occupancy. Prescribes additional medications to treat what are clearly withdrawal symptoms. If any of these apply, seek another opinion.

This website is a project of Fuller Research, a nonprofit dedicated to investigating medication-induced neurological injuries and advocating for patient safety.

If you want to support further research, advocacy, and the expansion of resources like this site, visit fullerresearch.org.

You can also help by sharing this website with anyone who needs it, patients, families, clinicians, journalists, and lawmakers. The more people who understand the scope of medication-induced harm, the harder it becomes for the medical establishment to dismiss it. Every person who reads this site and recognizes their own experience is one fewer person who has to suffer in silence believing they are the only one.

Akathisia is exceedingly difficult to treat and there is no single reliable cure. What works varies significantly between individuals. The following approaches have documented evidence or widespread patient-reported benefit:

Remove the cause. The most important step is identifying and removing the medication that triggered the akathisia. If it was recently started or recently increased, the offending change should be reversed promptly, akathisia is a life-threatening emergency, and dependence has not yet formed at the new dose. If you have been on the medication long-term, hyperbolic tapering is suggested, and if not tolerated, abrupt cessation may be worth the risk, talk to your doctor who is very familiar with akathisia to discuss your case specifically.

Opioid therapy. There is peer-reviewed evidence dating back to the 1980s that low to moderate dose opioid therapy (such as oxycodone) can substantially reduce or completely suppress akathitic restlessness. Research suggests this works because akathisia involves underactivity of the endogenous opioid system, opioids directly address the neurological deficit. This is not widely prescribed because most physicians are unfamiliar with the evidence, but the research is there: Walters et al. (1986) showed all patients had substantial to complete improvement on opioids in a placebo-controlled trial. This may seem counterintuitive but if a patient is suicidal, opiates are a completely reasonable option to avoid suicide. A 2021 comprehensive review (Zareifopoulos et al.) covering 8,481 articles confirmed opioids are particularly effective for acute akathisia due to their immediate onset of therapeutic benefit, and stated that the care of patients with treatment-resistant chronic akathisia "is essentially palliative," supporting opioid use when other treatments have failed. However, opioid therapy carries its own significant risks, including dependence, addiction, and respiratory depression, and should only be used if there is absolutely no other option. Other medications sometimes used include low-dose mirtazapine and propranolol, though these appear less effective than opioids and can paradoxically trigger or worsen akathisia in some patients.

Ketogenic diet. Some patients report significant relief with strict ketogenic or carnivore diet adherence. The mechanism is not fully understood but may involve ketone-mediated neuroprotection, reduced neuroinflammation, and stabilization of neuronal excitability. This is not a quick fix, it typically requires weeks of strict adherence before benefits emerge.

Eliminate all unnecessary medications and supplements. Polypharmacy worsens akathisia. Every additional psychoactive medication is a potential contributor. Supplements can also be problematic. Work with a knowledgeable clinician to systematically reduce the pharmacological burden on the nervous system.

Time. For many patients, the most reliable path to resolution is time, but only after the causative agent has been identified and addressed. Akathisia can resolve. The critical variable is surviving long enough to reach that point. If you need support, please visit our support communities to connect with others who understand what you are going through.

For the full body of research on akathisia and its treatment, see our akathisia research section. For detailed information on akathisia across specific medication classes, see our pages on SSRIs, SNRIs, and antipsychotics.